Aminoglycoside pretreatment partially restores the function of truncated V2 vasopressin receptors found in patients with nephrogenic diabetes insipidus

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 11, 2002, Pages 5247-5257

  Schulz, Angela ^a,b,c,d   Sangkuhl, Katrin ^a,b,c,d   Lennert, Thomas ^a,b,c,d   Wigger, Marianne ^a,b,c,d   Price, David Anthony ^a,b,c,d   Nuuja, Anja ^a,b,c,d   Grüters, Annette ^a,b,c,d   Schultz, Günter ^a,b,c,d   Schöneberg, Torsten ^a,b,c,d,e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^d JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; VASOPRESSIN V2 RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INACTIVATION; GENE LOCUS; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; MALE; MEMBRANE BINDING; MISSENSE MUTATION; MOLECULAR GENETICS; MULTIGENE FAMILY; NEPHROGENIC DIABETES INSIPIDUS; PRIORITY JOURNAL; X CHROMOSOME LINKAGE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CODON; COS CELLS; CRICETINAE; DIABETES INSIPIDUS, NEPHROGENIC; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE DELETION; GENE EXPRESSION; GENTAMICINS; HUMANS; LINKAGE (GENETICS); MALE; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, VASOPRESSIN; SEQUENCE ALIGNMENT; TRANSFECTION; X CHROMOSOME;

EID: 0036847111     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020286     Document Type: Article

References (24)

1. Schöneberg T, Schulz A, Gudermann T 2002 The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. Rev Physiol Biochem Pharmacol 144:143-227
2. Bichet DG 1998 Nephrogerdc diabetes insipidus. Am J Med 105:431-442
3. 2 vasopressin receptor mutants. J Clin Invest 105:887-895
4. Gudermann T, Schöneberg T, Schultz G 1997 Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu Rev Neurosci 20:399-427
5. 2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J 15:1283-1291
6. Palmer E, Wilhelm JM, Sherman F 1979 Phenotypic suppression of nonsense mutants in yeast by aminoglycoside antibiotics. Nature 277:148-150
7. Singh A, Ursic D, Davies J 1979 Phenotypic suppression and misreading in Saccharomyces cerevisiae. Nature 277:146-148
8. Arthus MF, Lonergan M, Crumley MJ, Naumova AK, Morin D, De Marco LA, Kaplan BS, Robertson GL, Sasaki S, Morgan K, Bichet DG, Fujiwara TM 2000 Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogemc diabetes insipidus. J Am Soc Nephrol 11:1044-1054
9. Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, Nagashima K, Morikawa A 1997 Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 82:3434-3437
10. 2 vasopressin receptor genes in a patient with nephrogenic diabetes insipidus. Hum Mutat 14:163-174
11. Salomon Y, Londos C, Rodbell M 1974 A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548
12. 2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms. Hum Mutat 12:196-205
13. Pasel K, Schulz A, Timmermann K, Linnemann K, Hoeltzenbein M, Jaaskelainen J, Grüters A, Filler G, Schöneberg T 2000 Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families. J Clin Endocrinol Metab 85:1703-1710
14. Schöneberg T, Sandig V, Wess J, Gudermann T, Schultz G 1997 Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. J Clin Invest 100:1547-1556
15. 2 vasopressin receptor gene mutations. Mol Cell Endocrinol 124:43-50
16. Friedman E, Carson E, Larson E, DeMarco L 1993 A polymorphism in the coding region of the vasopressin type 2 receptor (V2-R) gene. Hum Mol Genet 10:1746
17. Howard M, Frizzell RA, Bedwell DM 1996 Aminoglycoside antibiotics restore CFTR function by overcoming premature stop codons. Nat Med 2:467-469
18. Bedwell DM, Kaenjak A, Benos DJ, Bebok Z, Bubien JK, Hong J, Tousson A, Clancy JP, Sorscher EJ 1997 Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med 3:1280-1284
19. Sadeghi HM, Innamorati G, Birnbaumer M 1997 An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Mol Endocrinol 11:706-713
20. Tribioli C, Droetto S, Bione S, Cesareni G, Torrisi MR, Lotti LV, Lanfrancone L, Toniolo D, Pelicci P 1996 An X chromosome-linked gene encoding a protein with characteristics of a rhoGAP predominantly expressed in hematopoietic cells. Proc Natl Acad Sci USA 93:695-699
21. Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL 1999 Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104:375-381
22. Wagner KR, Hamed S, Hadley DW, Gropman AL, Burstein AH, Escolar DM, Hoffman EP, Fischbeck KH 2001 Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol 49:706-711
23. Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Atkins JF 2000 Sequence specificity of aminoglycoside-induced stop condon read-through: Potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 48:164-169
24. Yun J, Schöneberg T, Liu J, Schulz A, Ecelbarger CA, Promeneur D, Nielsen S, Sheng H, Grinberg A, Deng C, Wess J 2000 Generation of a mouse model for X-linked nephrogenic diabetes insipidus. J Clin Invest 106:1361-1371